Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'arsenic trioxide' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 126 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fenaux, P; Chomienne, C; Degos, L
      Treatment of acute promyelocytic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Pollock, JL; Westervelt, P; Walter, MJ; Lane, AA; Ley, TJ
      Mouse models of acute promyelocytic leukemia

      CURRENT OPINION IN HEMATOLOGY
    3. Powell, BL
      Acute progranulocytic leukemia

      CURRENT OPINION IN ONCOLOGY
    4. Zhang, TD; Chen, GQ; Wang, ZG; Wang, ZY; Chen, SJ; Chen, Z
      Arsenic trioxide, a therapeutic agent for APL

      ONCOGENE
    5. Benoit, G; Roussel, M; Pendino, F; Segal-Bendirdjian, E; Lanotte, M
      Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

      ONCOGENE
    6. Roussel, MJS; Lanotte, M
      Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

      ONCOGENE
    7. Pandolfi, PP
      Transcription therapy for cancer

      ONCOGENE
    8. Nicolis, I; Deschamps, P; Curis, E; Corriol, O; Acar, V; Zerrouk, N; Chaumeil, JC; Guyon, F; Benazeth, S
      XAS applied to pharmaceuticals: drug administration and bioavailability

      JOURNAL OF SYNCHROTRON RADIATION
    9. Lehmann, S; Bengtzen, S; Paul, A; Christensson, B; Paul, C
      Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance

      EUROPEAN JOURNAL OF HAEMATOLOGY
    10. Xu, L; Zhao, WL; Xiong, SM; Su, XY; Zhao, M; Wang, C; Gao, YR; Niu, C; Cao, Q; Gu, BW; Zhu, YM; Gu, J; Hu, J; Yan, H; Shen, ZX; Chen, Z; Chen, SJ
      Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia

      LEUKEMIA
    11. Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y
      A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

      LEUKEMIA
    12. Shen, Y; Shen, ZX; Yan, H; Chen, J; Zeng, XY; Li, JM; Li, XS; Wu, W; Xiong, SM; Zhao, WL; Tang, W; Wu, F; Liu, YF; Niu, C; Wang, ZY; Chen, SJ; Chen, Z
      Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

      LEUKEMIA
    13. Porosnicu, M; Nimmanapalli, R; Nguyen, D; Worthington, E; Perkins, C; Bhalla, KN
      Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells

      LEUKEMIA
    14. Lallemand-Breitenbach, V; Zhu, J; de The, H
      Promyelocytic leukemia, a unique model to design treatments targeting oncogenes

      M S-MEDECINE SCIENCES
    15. Ozpolat, B; Lopez-Berestein, G; Mehta, K
      ATRA(ouble) in the treatment of acute promyelocytic leukemia

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    16. Tong, QS; Zeng, FQ; Zheng, LD; Zhao, J; Lu, GC
      Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87

      CHINESE MEDICAL JOURNAL
    17. Jia, PM; Chen, GQ; Huang, XJ; Cai, X; Yang, J; Wang, L; Zhou, YH; Shen, YL; Zhou, L; Yu, Y
      Arsenic trioxide induces multiple myeloma cell apoptosis via disruption ofmitochondrial transmembrane potentials and activation of caspase-3

      CHINESE MEDICAL JOURNAL
    18. Guo, WM; Wang, HL; Zhao, WL; Zhu, J; Ju, B; Wang, XF
      Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells

      CHINESE MEDICAL JOURNAL
    19. Kwong, YL; Au, WY; Chim, CS; Pang, A; Suen, C; Liang, R
      Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study

      AMERICAN JOURNAL OF HEMATOLOGY
    20. Wang, ZY
      Arsenic compounds as anticancer agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Du, YH; Ho, PC
      Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitiveand -resistant gynecological cancer cell lines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    22. Debekaussen, R; Droppert, D; Demopoulos, GP
      Ambient pressure hydrometallurgical conversion of arsenic trioxide to crystalline scorodite

      CIM BULLETIN
    23. Banu, BS; Danadevi, K; Jamil, K; Ahuja, YR; Rao, KV; Ishaq, M
      In vivo genotoxic effect of arsenic trioxide in mice using comet assay

      TOXICOLOGY
    24. Wu, WS; Vallian, S; Seto, E; Yang, WM; Edmondson, D; Roth, S; Chang, KS
      The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases

      MOLECULAR AND CELLULAR BIOLOGY
    25. Nabhan, C; Mehta, J; Tallman, MS
      The role of bone marrow transplantation in acute promyelocytic leukemia

      BONE MARROW TRANSPLANTATION
    26. Wei, YM; Ou, MX; Bai, H; Lu, JH; Zheng, RL
      Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines

      ACTA PHARMACOLOGICA SINICA
    27. Yu, D; Wang, ZH; Cheng, SB; Li, HK; Chan, HB; Chew, EC
      The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells

      ANTICANCER RESEARCH
    28. Wang, ZH; Yu, D; Li, HK; Chow, VW; Ng, CC; Chan, HB; Cheng, SB; Chew, EC
      Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment

      ANTICANCER RESEARCH
    29. Yuan, ZL; Huang, X; Zhang, WP; Zhang, MH; Wan, T; Cao, XT
      Cloning and characterization of a novel zinc finger protein (MDZF) that isassociated with monocytic differentiation of acute promyelocytic leukemia cells

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    30. Tarello, W
      Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies

      COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
    31. Tarello, W
      Chronic Fatigue Syndrome in horses: diagnosis and treatment of 4 cases

      COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
    32. Shearer, PD; Pui, CH
      The walls of a spacious room

      MEDICAL AND PEDIATRIC ONCOLOGY
    33. Zhao, WL; Wang, HL; Wang, XF; Wu, P; Guo, WM; Qu, B; Shen, ZX; Wang, ZY
      Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia

      THROMBOSIS RESEARCH
    34. Rego, EM; Pandolfi, PP
      Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models

      SEMINARS IN HEMATOLOGY
    35. Burkham, J; Coen, DM; Hwang, CBC; Weller, SK
      Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments

      JOURNAL OF VIROLOGY
    36. Rego, EM; Wang, ZG; Peruzzi, D; He, LZ; Cordon-Cardo, C; Pandolfi, PP
      Role of promyelocytic leukemia (PML) protein in tumor suppression

      JOURNAL OF EXPERIMENTAL MEDICINE
    37. Kogan, SC; Brown, DE; Shultz, DB; Truong, BTH; Lallemand-Breitenbach, V; Guillemin, MC; Lagasse, E; Weissman, IL; Bishop, JM
      BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia

      JOURNAL OF EXPERIMENTAL MEDICINE
    38. He, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
      Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

      JOURNAL OF CLINICAL INVESTIGATION
    39. Iwama, K; Nakajo, S; Aiuchi, T; Nakaya, K
      Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent productionof superoxide

      INTERNATIONAL JOURNAL OF CANCER
    40. Fatouros, D; Gortzi, O; Klepetsanis, P; Antimisiaris, SG; Stuart, MCA; Brisson, A; Ioannou, PV
      Preparation and properties of arsonolipid containing liposomes

      CHEMISTRY AND PHYSICS OF LIPIDS
    41. Bachleitner-Hofmann, T; Gisslinger, B; Grumbeck, E; Gisslinger, H
      Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?

      BRITISH JOURNAL OF HAEMATOLOGY
    42. Vernhet, L; Allain, N; Payen, L; Anger, JP; Guillouzo, A; Fardel, O
      Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide

      BIOCHEMICAL PHARMACOLOGY
    43. Park, JW; Choi, YJ; Jang, MA; Baek, SH; Lim, JH; Passaniti, T; Kwon, TK
      Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    44. Lengfelder, E; Hehlmann, R; Buchner, T
      Current therapeutic concept of acute promyelocytic leukaemia

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    45. Griffin, RJ; Lee, SH; Rood, KL; Stewart, MJ; Lyons, JC; Lew, YS; Park, H; Song, CW
      Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors

      NEOPLASIA
    46. Maslak, P; Scheinberg, D
      Targeted therapies for the myeloid leukaemias

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    47. Douer, D
      Transcription therapy for acute promyelocytic leukaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    48. Shen, ZY; Shen, J; Cai, WJ; Hong, CQ; Zheng, MH
      The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    49. Berman, E
      Recent advances in the treatment of acute leukemia: 1999

      CURRENT OPINION IN HEMATOLOGY
    50. Huang, SY; Yang, CH; Chen, YC
      Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy

      LEUKEMIA & LYMPHOMA
    51. Alemany, M; Levin, J
      The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines - With a comparison of its effects on other cell lineages

      LEUKEMIA & LYMPHOMA
    52. Ishitsuka, K; Hanada, S; Uozumi, K; Utsunomiya, A; Arima, T
      Arsenic trioxide and the growth of human T-Cell leukemia virus type I infected T-Cell lines

      LEUKEMIA & LYMPHOMA
    53. Akao, Y; Yamada, H; Nakagawa, Y
      Arsenic-induced apoptosis in malignant cells in vitro

      LEUKEMIA & LYMPHOMA
    54. Slack, JL; Rusiniak, ME
      Current issues in the management of acute promyelocytic leukemia

      ANNALS OF HEMATOLOGY
    55. Shinjo, K; Takeshita, A; Ohnishi, K; Sakura, T; Miyawaki, S; Hiraoka, A; Takeuchi, M; Tomoyasu, S; Wakita, H; Ata, K; Fukutani, H; Ueda, R; Ohno, R
      Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, AM80, after relapse from CR induced by all-trans-retinoic acid

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    56. Takahashi, N; Kubo, Y; Iwahori, A; Kawai, K; Fukui, T
      Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    57. Zhang, WJ; Ohnishi, K; Yoshida, H; Pan, L; Maksumova, L; Muratkhodjaev, F; Luo, JM; Shigeno, K; Fujisawa, S; Naito, K; Nakamura, S; Shinjo, K; Takeshita, A; Ohno, R
      Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lineswith down-regulation of Bcl-2 expression and modulation of promyelocytic leukemia protein

      JAPANESE JOURNAL OF CANCER RESEARCH
    58. Zhang, T; Westervelt, P; Hess, JL
      Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3)

      MODERN PATHOLOGY
    59. O'Donnell, MR; Appelbaum, FR; Baer, MR; Carabasi, MH; Coutre, SE; Erba, HP; Estey, E; Glenn, MJ; Kraut, EH; Maslak, P; Millenson, M; Miller, CB; Saba, HI; Stone, R; Tallman, MS
      NCCN Practice Guidelines for acute myelogenous leukemia

      ONCOLOGY-NEW YORK
    60. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
      Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

      LEUKEMIA
    61. Thomas, X; Dombret, H; Cordonnier, C; Pigneux, A; Gardin, C; Guerci, A; Vekhoff, A; Sadoun, A; Stamatoullas, A; Fegueux, N; Maloisel, F; Cahn, JY; Reman, O; Gratecos, N; Berthou, C; Huguet, F; Kotoucek, P; Travade, P; Buzyn, A; de Revel, T; Vilque, JP; Naccache, P; Chomienne, C; Degos, L; Fenaux, P
      Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

      LEUKEMIA
    62. Kinjo, K; Kizaki, M; Muto, A; Fukuchi, Y; Umezawa, A; Yamato, K; Nishihara, T; Hata, J; Ito, M; Ueyama, Y; Ikeda, Y
      Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice

      LEUKEMIA
    63. Cai, X; Shen, YL; Zhu, Q; Jia, PM; Yu, Y; Zhou, L; Huang, Y; Zhang, JW; Xiong, SM; Chen, SJ; Wang, ZY; Chen, Z; Chen, GQ
      Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

      LEUKEMIA
    64. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
      Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

      LEUKEMIA
    65. Zhang, TC; Cao, EH; Li, JF
      A laser scanning confocal microscopy method - Simultaneous detection of intracellular Ca2+ and apoptosis using Fluo-3 and Hoechst 33342

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    66. Chim, CS; Liang, R; Tam, CYY; Kwong, YL
      Methylation of p15 and p16 genes in acute promyelocytic leukemia: Potential diagnostic and prognostic significance

      JOURNAL OF CLINICAL ONCOLOGY
    67. Shen, L; Chen, TX; Wang, YP; Lin, Z; Zhao, HJ; Zu, YZ; Wu, G; Ying, DM
      As2O3 induces apoptosis of the human B lymphoma cell line MBC-1

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    68. Donelli, A; Chiodino, C; Panissidi, T; Roncaglia, R; Torelli, G
      Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?

      HAEMATOLOGICA
    69. Huang, XJ
      Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells

      CHINESE MEDICAL JOURNAL
    70. Zhao, WL; Wang, XF; Guo, WM; Qu, B; Wang, HL; Shen, ZX; Chen, Z; Wang, ZY
      Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment

      CHINESE MEDICAL JOURNAL
    71. Hu, J; Shen, ZX; Sun, HP; Wu, W; Li, XS; Sun, GL; Wang, ZY
      Long-term survey of outcome in acute promyelocytic leukemia

      CHINESE MEDICAL JOURNAL
    72. Barrett, SV; Barrett, MF
      Anti-sleeping sickness drugs and cancer chemotherapy

      PARASITOLOGY TODAY
    73. Falnoga, I; Stilbilj, V; Tusek-Znidaric, M; Slejkovec, Z; Mazej, D; Jacimovic, R; Scancar, J
      Effect of arsenic trioxide on metallothionein and its conversion to different arsenic metabolites in hen liver

      BIOLOGICAL TRACE ELEMENT RESEARCH
    74. Cheson, BD; Zwiebel, JA; Dancey, J; Murgo, A
      Novel therapeutic agents for the treatment of myelodysplastic syndromes

      SEMINARS IN ONCOLOGY
    75. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
      Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    76. Kennedy, GA; Marlton, P; Cobcroft, R; Gill, D
      Molecular remission without blood product support using all-trans retinoicacid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    77. Walter, R; Schoedon, G; Bachli, E; Betts, DR; Hossle, JP; Calandra, T; Joller-Jemelka, HI; Fehr, J; Schaffner, A
      Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5)

      BRITISH JOURNAL OF HAEMATOLOGY
    78. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
      Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Sainty, D; Liso, V; Cantu-Rajnoldi, A; Head, D; Mozziconacci, MJ; Arnoulet, C; Benattar, L; Fenu, S; Mancini, M; Duchayne, E; Mahon, FX; Gutierrez, N; Birg, F; Biondi, A; Grimwade, D; Lafage-Pochitaloff, M; Hagemeijer, A; Flandrin, G
      A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

      BLOOD
    80. Grimwade, D; Biondi, A; Mozziconacci, MJ; Hagemeijer, A; Berger, R; Neat, M; Howe, K; Dastugue, N; Jansen, J; Radford-Weiss, I; Lo Coco, F; Lessard, M; Hernandez, JM; Delabesse, E; Head, D; Liso, V; Sainty, D; Flandrin, G; Solomon, E; Birg, F; Lafage-Pochitaloff, M
      Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party

      BLOOD
    81. Nicot, C; Mahieux, R; Takemoto, S; Franchini, G
      Bcl-X-L is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLLsamples

      BLOOD
    82. Ora, I; Bondesson, L; Jonsson, C; Ljungberg, J; Porn-Ares, I; Garwicz, S; Pahlman, S
      Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    83. Ren, XQ; Furukawa, T; Chen, ZS; Okumura, H; Aoki, S; Sumizawa, T; Tani, A; Komatsu, M; Mei, XD; Akiyama, S
      Functional comparison between VCF1 and MRP1 expressed in Sf21 insect cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    84. Schrantz, N; Blanchard, DA; Mitenne, F; Auffredou, MT; Vazquez, A; Leca, G
      Manganese induces apoptosis of human B cells: caspase-dependent cell deathblocked by Bcl-2

      CELL DEATH AND DIFFERENTIATION
    85. Kizaki, M; Fukuchi, Y; Ikeda, Y
      A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    86. Shen, ZY; Tan, LJ; Cai, WJ; Shen, J; Chen, C; Tang, XM; Zheng, MH
      Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    87. Holson, JF; Stump, DG; Ulrich, CE; Farr, CH
      Absence of prenatal developmental toxicity from inhaled arsenic trioxide in rats

      TOXICOLOGICAL SCIENCES
    88. Deng, YP; Lin, C; Zheng, J; Liang, X; Chen, JP; Fu, M; Xiao, PG; Wu, M
      Mechanisms of arsenic trioxide induced apoptosis of human cervical cancer HeLa cells and protection by Bcl-2

      SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    89. Xie, DX; Ding, F; Wang, XQ; Liu, ZH; Luo, AP; Wu, M
      Comparison of differential gene expression profiles in human esophageal squamous carcinoma EC8712 cells before and after arsenic trioxide (As2O3) treatment

      CHINESE SCIENCE BULLETIN
    90. Seeler, JS; Dejean, A
      The PML nuclear bodies: actors or extras?

      CURRENT OPINION IN GENETICS & DEVELOPMENT
    91. Kogan, SC; Bishop, JM
      Acute promyelocytic leukemia: from treatment to genetics and back

      ONCOGENE
    92. He, LZ; Merghoub, T; Pandolfi, PP
      In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

      ONCOGENE
    93. Agis, H; Weltermann, A; Mitterbauer, G; Thalhammer, R; Edelhauser, M; Seewann, HL; Valent, P; Lechner, K; Fonatsch, C; Geissler, K
      Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia

      ANNALS OF HEMATOLOGY
    94. Hu, J; Shen, ZX; Sun, GL; Chen, SJ; Wang, ZY; Chen, Z
      Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    95. Barchowsky, A; Klei, LR; Dudek, EJ; Swartz, HM; James, PE
      Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite

      FREE RADICAL BIOLOGY AND MEDICINE
    96. Gianni, M; de The, H
      In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies

      LEUKEMIA
    97. Zhang, P
      The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS

    98. Hematology in China

      HAEMATOLOGICA
    99. Marasca, R; Zucchini, P; Galimberti, S; Leonardi, G; Vaccari, P; Donelli, A; Luppi, M; Petrini, M; Torelli, G
      Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia

      HAEMATOLOGICA
    100. Wang, ZY; Sun, GL; Shen, ZX; Chen, SJ; Chen, Z
      Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application

      CHINESE MEDICAL JOURNAL


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:25:45